Jan Willem W Coebergh
Overview
Explore the profile of Jan Willem W Coebergh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
2606
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reedijk A, Beishuizen A, Coebergh J, Hoeben B, Kremer L, Hebeda K, et al.
Eur J Cancer
. 2022 Jan;
163:140-151.
PMID: 35074650
Background: With epidemiologic analyses of population-based trends in incidence and outcomes, we ascertained progress against non-Hodgkin's lymphoma (NHL) in children and young adolescents in the Netherlands since 1990. Methods: Tumour...
2.
Reedijk A, Coebergh J, de Groot-Kruseman H, van der Sluis I, Kremer L, Karim-Kos H, et al.
Leukemia
. 2020 Aug;
35(4):1001-1011.
PMID: 32820270
We assessed the epidemiologic progress against childhood and adolescent acute lymphoblastic leukaemia (ALL) in the Netherlands over a 26 year period. ALL patients <18 years were selected from the Netherlands...
3.
Reedijk A, Kremer L, Visser O, Lemmens V, Pieters R, Coebergh J, et al.
Eur J Cancer
. 2020 Jun;
134:115-126.
PMID: 32521425
Background: This is the first national study on trends in cancer incidence for children and young adolescents in the Netherlands, including stage at diagnosis as a potential marker of early...
4.
Reedijk A, Zijtregtop E, Coebergh J, Meyer-Wentrup F, Hebeda K, Zwaan C, et al.
Br J Haematol
. 2020 Feb;
189(6):1093-1106.
PMID: 32030738
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and survival are virtually lacking for Hodgkin lymphoma (HL) at a younger age. This study assessed the progress...
5.
Lortet-Tieulent J, Soerjomataram I, Lin C, Coebergh J, Jemal A
Am J Prev Med
. 2016 Oct;
51(5):673-681.
PMID: 27745677
Introduction: In the U.S., people of different races/ethnicities have differences in cancer incidence, mortality, survival, stage at diagnosis, and receipt of treatment, resulting in variances in cancer burden. The burden...
6.
Coebergh J
Ned Tijdschr Geneeskd
. 2014 Dec;
158:A8574.
PMID: 25515394
A Dutch research group has calculated how much cancer in the Netherlands can be prevented and how much the incidence of cancer deaths could be diminished by reducing pathogenic factors...
7.
Issa D, van de Schans S, Chamuleau M, Karim-Kos H, Wondergem M, Huijgens P, et al.
Haematologica
. 2014 Dec;
100(4):525-33.
PMID: 25512643
Only a small number of patients with aggressive B-cell lymphoma take part in clinical trials, and elderly patients in particular are under-represented. Therefore, we studied data of the population-based nationwide...
8.
Joosse A, van der Ploeg A, Haydu L, Nijsten T, de Vries E, Scolyer R, et al.
Ann Surg Oncol
. 2014 Nov;
22(5):1598-603.
PMID: 25408275
Purpose: Based on prior studies, we concluded that the female advantage in melanoma survival is caused by biological factors and not by differences in patient behavior. In this study, we...
9.
van den Broek E, Oerlemans S, Nijziel M, Posthuma E, Coebergh J, van de Poll-Franse L
Ann Hematol
. 2014 Jul;
94(1):45-56.
PMID: 25038918
As survival of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) increases and the number of patients who live long rises, health-related quality of life (HRQoL) becomes a relevant endpoint....
10.
Oerlemans S, Mols F, Nijziel M, Zijlstra W, Coebergh J, van de Poll-Franse L
J Cancer Surviv
. 2014 May;
8(4):555-64.
PMID: 24820429
Purpose: The purpose of this study is to prospectively assess anxiety and depression among patients with Hodgkin lymphoma (HL) and diffuse large B cell lymphoma (DLBCL). Also, to compare its...